Peter Andersen

Medicine and Dentistry

1. Alcohol-Related Liver Disease 100%
2. Liver Disease 85%
3. Liver Fibrosis 70%
4. Fibrosis 69%
5. Alcohol Consumption 51%
6. Prospective Cohort Study 45%
7. Transient Elastography 29%
8. Primary Health Care 22%
9. Randomized Controlled Trial 17%
10. Nonalcoholic Fatty Liver 16%
11. Non-Alcoholic Fatty Liver Disease 15%
12. Maturity Onset Diabetes of the Young 14%
13. Liver Biopsy 13%
14. Placebo 13%
15. Low Fat Diet 13%
16. Rifaximin 13%
17. Lifestyle Modification 13%
18. Infection 13%
19. High Fat Food 13%
20. Nutritional Support 13%
21. Prevalence 13%
22. Secondary Care 12%
23. Gut 12%
24. Abstinence 10%
25. Chronic Liver Disease 10%
26. Protein Concentrate Plus Carbohydrates Plus Lipids Plus Minerals Plus Vitamins 9%
27. Metabolic Dysfunction-Associated Steatotic Liver Disease 9%
28. Adverse Event 9%
29. Decompensated Liver Cirrhosis 9%
30. Biopsy Technique 8%
31. Odds Ratio 7%
32. Platelet 7%
33. Screening Test 6%
34. Intention-to-Treat Analysis 6%
35. All Cause Mortality 6%
36. Hazard Ratio 6%
37. Patient Referral 5%
38. Risk Stratification 5%
39. Focused Ion Beam 5%
40. Carbohydrate Deficient Transferrin 5%